GSK Seeks Second Shot At Pfizer Vaccine Patent Fight
GSK asked a London court on Friday to allow it to challenge a decision to nix two patents protecting its blockbuster vaccine for the respiratory syncytial virus, arguing that a judge...To view the full article, register now.
Already a subscriber? Click here to view full article